Recruiting Myeloproliferative Neoplasms Studies in Oklahoma City
About Myeloproliferative Neoplasms Clinical Trials in Oklahoma City
Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.
There are currently 1 myeloproliferative neoplasms clinical trials recruiting participants in Oklahoma City, OKLAHOMA. These studies are seeking a combined 62 participants. Research is being sponsored by National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.
Myeloproliferative Neoplasms Clinical Trials in Oklahoma City — FAQ
Are there myeloproliferative neoplasms clinical trials in Oklahoma City?
Yes, there are 1 myeloproliferative neoplasms clinical trials currently recruiting in Oklahoma City, OKLAHOMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Oklahoma City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oklahoma City research site will contact you about next steps.
Are clinical trials in Oklahoma City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oklahoma City studies also compensate for your time and travel.
What myeloproliferative neoplasms treatments are being tested?
The 1 active trials in Oklahoma City are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.
Data updated March 2, 2026 from ClinicalTrials.gov